Literature DB >> 1868434

Evidence supporting exclusion of the DCC gene and a portion of chromosome 18q as the locus for susceptibility to hereditary nonpolyposis colorectal carcinoma in five kindreds.

P Peltomäki1, P Sistonen, J P Mecklin, L Pylkkänen, H Järvinen, J W Simons, K R Cho, B Vogelstein, A de la Chapelle.   

Abstract

Hereditary non-polyposis colorectal carcinoma (HNPCC) syndrome is characterized by early onset and multiple cancers of predominantly the proximal colon and occasionally other organs. The mode of transmission is compatible with autosomal dominant inheritance but the location and characteristics of the putative susceptibility gene are unknown. We performed linkage analyses with the aim of proving or excluding the existence of a susceptibility locus on 18q. This hypothesis was based on the frequent involvement of the DCC gene in colorectal carcinoma and on the previously reported linkage between HNPCC and the Kidd blood group locus (JK) also on 18q. Seven HNPCC families were tested with eight polymorphisms, including three from within DCC. The DCC locus could be excluded as the HNPCC susceptibility locus in five families in which the two point logarithm-of-odds scores were -3.66, -3.63, -4.12, -7.90, and -3.74 at the recombination fraction of 0.00. In the remaining two families linkage could be neither excluded nor confirmed. The added pairwise logarithm-of-odds score for all seven families was -22.65 at the recombination fraction of 0.00. Multipoint analyses of linkage in the seven families suggested exclusion of some 60 cM in the region DCC-D18S18-D18S22-D18S7 as the site for HNPCC susceptibility locus. In addition to DCC, the excluded portion comprises JK.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868434

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  A new class of colorectal cancer gene.

Authors:  L Cawkwell; P Quirke
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

Review 2.  Molecular biology of colorectal neoplasia.

Authors:  N Scott; P Quirke
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

3.  Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours.

Authors:  Paul Krimpenfort; Ji-Ying Song; Natalie Proost; John Zevenhoven; Jos Jonkers; Anton Berns
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

Review 4.  Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Authors:  David G Menter; Jennifer S Davis; Bradley M Broom; Michael J Overman; Jeffrey Morris; Scott Kopetz
Journal:  Curr Gastroenterol Rep       Date:  2019-01-30

5.  Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families.

Authors:  M Nyström-Lahti; P Sistonen; J P Mecklin; L Pylkkänen; L A Aaltonen; H Järvinen; J Weissenbach; A de la Chapelle; P Peltomäki
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

6.  Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.

Authors:  Sung Kwan Shin; Takeshi Nagasaka; Barbara H Jung; Nagahide Matsubara; Won Ho Kim; John M Carethers; C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2007-09-05       Impact factor: 22.682

7.  Exclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer.

Authors:  T Bhagirath; A Condie; M G Dunlop; A H Wyllie; J Prosser
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

Review 8.  Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients' Stratification.

Authors:  Elena Ionica; Gisela Gaina; Mihaela Tica; Mariana-Carmen Chifiriuc; Gratiela Gradisteanu-Pircalabioru
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

9.  Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

Authors:  A M Thompson; R G Morris; M Wallace; A H Wyllie; C M Steel; D C Carter
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.